Skip Navigation

eCAM 2009 6(Supplement 1):81-86; doi:10.1093/ecam/nep098
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Lee, S.-W.
Right arrow Articles by Kwon, K.-B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, S.-W.
Right arrow Articles by Kwon, K.-B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© 2009 The Author(s).
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Taeyeumjoweetang Affects Body Weight and Obesity-related Genes in Mice

Si-Woo Lee1, Jong-Hyang Yoo1, Su-Kyung Lee2, Kyung-Soo Keum3, Do-Gon Ryu4 and Kang-Beom Kwon4

1Korea Institute of Oriental Medicine, Daejeon, South Korea, 2Department of Rehabilitation, 3Department of Classics and 4Department of Physiology, College of Oriental Medicine, Wonkwang University, Iksan, Chonbuk, Republic of Korea


   Abstract
Top
 Abstract
Introduction
 Methods
 Results
 Discussion
 Funding
 References
 
Taeyeumjoweetang (TYJWT) is a herbal medication that was mentioned in Jema Lee's Donguisusebowon, which is a book about Sasang constitutional medicine. Tae-eumnis, one of the four constitutions, tend to suffer from metabolic diseases such as obesity and diabetes. It is widely used to treat the digestive problems and obesity of Tae-eumins. We divided mice that were fed a normal diet for 48 days into control, TYJWT 250 mg kg–1 and TYJWT 500 mg kg–1 groups. After carrying out the experiments, the serum levels of leptin, adiponectin, ghrelin and resistin were measured. The results showed that TYJWT significantly reduced the weights of mice that were fed a normal diet, and that this was due to a decrease in food intake. Also, the two TYJWT groups had lower serum levels of leptin compared to the control group, and the ghrelin levels were proportionately increased by the dosage of TYJWT given. These results show that TYJWT has obesity-suppressing effects similar to those previously reported using high fat diets. In addition, these results also provide evidence that TYJWT has anti-obesity effects.

Keywords: ghrelin – leptin – Sasang constitutional medicine


   Introduction
Top
 Abstract
 Introduction
Methods
 Results
 Discussion
 Funding
 References
 
Taeyeumjoweetang (TWJWT) was first mentioned by Jema Lee (1837–1900) in Donguisusebowon as a herbal medication consisting of eight herbs, which is used to treat ‘exterior-cold disease by cold in the esophagus’ of Tae-eumin (1). To date, research on the anti-obesity effects of TYJWT showed that it suppressed the weights and serum lipid profiles of obese mice induced by a high-fat diet (2), its herbal acupuncture form improved the high-fat-diet-induced lipid profiles of serum and the liver (3) and that it suppressed leptin gene expression in obese mice (4).

Obesity is a chronic metabolic disorder caused by an imbalance between energy intake and usage, and is characterized by weight gain due to an increase in body fat and serum lipid content (5,6). Recent research shows that several substances are secreted by adipose cells that either cause or improve obesity. Among these, leptin and resistin are important factors that control weight, although their exact roles have not yet been defined (7). Ghrelin is secreted by the stomach (8) and its synthesis and secretion are primarily controlled by changes in body energy. Its secretion is increased when the energy level is low and secretion decreases when the energy level is high (9). Ghrelin expression is also controlled by leptin (10).

To date, research into the anti-obesity effects of TYJWT have used obese animal models that were induced by a high-fat diet (2–4). TYJWT has been widely used for treatment of Tae-eumins’ obesity in Korea. In order to closely approach the clinical condition, we explored the effects of TYJWT on mice that were fed a normal diet. For 48 days, we measured the weights and food intakes of mice that were given 250 and 500 mg kg–1 doses of TYJWT, as well as the levels of serum leptin, resistin, ghrelin and adiponectin.


   Methods
Top
 Abstract
 Introduction
 Methods
Results
 Discussion
 Funding
 References
 
Test Animals

We purchased 30 C57BL/6J male mice (20–25 g) that were 3 weeks old from Central Lab. Animal Inc. The mice were adapted to the test environment by being fed standard experiment diet for 1 week. The mice were raised in a controlled environment (temperature at 20°C, 50% humidity, light cycle from 06 : 00 to 18 : 00 hours and dark cycle from 18 : 00 to 06 : 00 hours), and during the experiment they were allowed to drink water freely. All these procedures involving the use of animals have been conducted in agreement with NIH Guidelines and approved by the Animal Use and Care Committee of Wonkwang University.

TYJWT Extraction Method

After purchasing TYJWT (Table 1) from Wonkwang Oriental Medical Hospital, it was certified by the Department of Herbology, College of Oriental Medicine, Wonkwang University before use. TYJWT (200 g) was placed in a round bottom flask with 1.8 l of triple distilled water. After attaching a freezer, it was boiled for 3 h, centrifuged at 3000 rpm for 20 min, decompressed and concentrated using a rotating vacuum concentrator. Using a freeze drying machine, 31.3 g of powder was obtained. This was stored at –70°C until used in experiments.


View this table:
[in this window]
[in a new window]

  		Table 1. Composition of TYJWT

 
Test Groups

The mice were divided into three groups and were fed for 48 days as follows. The control group was fed a normal diet and was given saline twice daily. The TYJWT groups were given oral doses of 250 and 500 mg kg–1 twice daily, at 09 : 00 and 21 : 00 hours. Weights and food intakes were measured every 4 days. After this period, the mice were decapitated, serum was separated, and separated epididymal fat and stomach were stored at –70°C until assayed.

ELISA

Serum concentrations for leptin, adiponectin, ghrelin and resistin were measured using ELISA kits (Roche Diagnostics, CA, USA) according to the manufacturer's protocols.

RNA Extraction

The extraction of total RNA from the stomach and fat tissues used Trizol reagent (Life Technologies, UK) according to the manufacturer's protocols. Tissue (100 mg) was cut into pieces, dissolved in 500 µl RNAzol B, 50 µl chloroform was added, and the reaction was run for 5 min on ice. After the reaction, samples were centrifuged at 15 700g at 4°C for 20 min, and then the upper layer was put in a new tube. An equal volume of isopropanol was added to the upper layer, and the reaction was run for 30 min. After the reaction, samples were centrifuged at 15 700g at 4°C for 20 min, and then the sediments were cleansed with 80% EtOH. The cleansed RNA was dried, melted with 20 of DEPC-treated water and the optical density was quantified using a spectrophotometer.

Real-Time Reverse Transcription Polymerase Chain Reaction

Reverse transcription reactions used 3–5 µg total RNA and reverse transcriptase (MMLV; Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. The reaction used a reaction solution of total RNA (3–5 µg), oligo d (T) 12–18 (1 µg), 2 µl dNTP (10 mM), MMLV reverse transcriptase (200 U), DTT (10 mM), RNase inhibitor (1 µl; Promega, USA) and a 20 µl buffer solution (50 mM Tris–Cl, pH 8.3, 75 mM KCl, 3 mM MgCl2) at 42°C for 60 min, after which cDNA was synthesized. Real-time reverse transcription polymerase chain reaction was done by mixing cDNA (diluted 10 times) with 2x SYBR-Green buffer solution (Roche Diagnostics Ltd, UK), which contained reverse transcription enzymes, using a LightCycler rapid thermal cycler system (Roche). In summary, after letting the reaction mixture react at 95°C for 10 min, 45 cycles of denaturation (95°C 10 s), annealing (58°C for leptin, ghrelin or 60°C for β-actin, 5 s) and elongation (72°C 10 s) were done. The expressed leptin and ghrelin concentrations were calculated relative to the amount of β-actin using LightCycler System software (Roche). The primers for leptin, ghrelin and β-actin are shown in Table 2.


View this table:
[in this window]
[in a new window]

  		Table 2. Sequences and accession numbers for primers used for real-time PCR

 
Statistical Analysis

Test results were expressed as mean ± SEM. Group comparisons used a one-way ANOVA test (Microcal Origin; version6.0; Microsoft, USA), with P < 0.05 considered statistically significant.


   Results
Top
 Abstract
 Introduction
 Methods
 Results
Discussion
 Funding
 References
 
Decrease of Body Weight

In order to explore the effects of TYJWT on weight changes of normal mice, 250 and 500 mg kg–1 oral doses of TYJWT were given for 48 days, and weight changes were measured every 4 days. As shown in Fig. 1, the control group mice, which were fed a normal diet, showed significant weight gains as time passed. However, the TYJWT groups showed significant weight losses compared to the control group starting at Day 36, and the weight loss effects in the 250 mg kg–1 group was more pronounced than the 500 mg kg–1 group (Fig. 1). Regarding food intake, starting at Day 36, the TYJWT groups ate less compared to the control group (Fig. 2).


Figure 1
View larger version (18K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Figure 1. Effects of TYJWT on body weight changes in mice. Control: normal diet group, n = 10; TYJWT (250): normal diet + 250 mg kg–1 TYJWT extract; TYJWT (500): normal diet + 500 mg kg–1 TYJWT extracts. Values are mean ± SEM. *P < 0.05 versus control.

 

Figure 2
View larger version (15K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Figure 2. Effects of TYJWT on food intake in mice.

 
Changes in Leptin and Ghrelin Expression

In order to find a relationship between the weight loss effects of TYJWT and appetite, we examined the serum levels of leptin and ghrelin, as well as their mRNA expressions in the fat and stomach tissues (Fig. 3). The results showed that the 500 mg kg–1 TYJWT group secreted significantly less leptin into the bloodstream compared to the control group, and the expression of leptin mRNA in fat tissue also coincided with this result. By comparison, the levels of ghrelin secreted into the serum as well as the expression of mRNA in the stomach tissue were proportionate to the dosage of TYJWT given.


Figure 3
View larger version (17K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Figure 3. Effects of TYJWT on leptin and ghrelin expressions in mice. Leptin and ghrelin concentrations in plasma were measured by ELISA; mRNA levels were measured by the real-time PCR assay as described in the ‘Methods’ section. Values are mean ± SEM. *P < 0.05 versus control.

 
Reduction in Secretions of Adiponectin and Resistin

In order to examine a weight loss mechanism for TYJWT, the levels of adiponectin and resistin secreted into the serum were measured (Fig. 4). The adiponectin levels of the two TYJWT groups were not significantly different from one another, but TYJWT reduced the amounts of resistin secreted into the bloodstream in a dose-dependent manner.


Figure 4
View larger version (13K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Figure 4. Effects of TYJWT on plasma adiponectin and resistin in mice. Adiponectin and resistin levels in plasma were measured by ELISA. Values are mean ± SEM. *P < 0.05 versus control.

 

   Discussion
Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
Funding
 References
 
Obesity is a metabolic disorder caused by excess energy intake relative to energy usage and is a state in which the supply of energy is so excessive that the remainder of energy accumulates in the body (11,12). Because obesity is strongly associated with depression, diabetes, hypertension, hyperlipidemia, coronary heart disease and arthritis, there have been numerous efforts to prevent and treat obesity. However, most medications used have significant side effects as well as hepatotoxicity, so their long-term use is impossible. And long-term medications that have been approved by the FDA, such as orlistat (Xenical) and sibutramine (Reductil), have been shown to suppress fat accumulation and induce weight loss, but have side effects like oily stool, physconia, undurable stool, headache, constipation, thirst, nausea, dizziness and insomnia (13,14). Therefore, research into herbal medications, which have been proven to have fewer side effects than these medications, is needed.

TYJWT is the most widely used clinical anti-obesity herbal medication. Although it has been reported on its positive effects for obesity many times (2–4), its anti-obesity mechanism has not yet been clarified. Tests that examined the anti-obesity effects of TYJWT have mainly used obese animal models that were induced by a high fat diet (2–4). In contrast, our research examined the effects of TYJWT on mice that were fed a normal diet. TYJWT extract significantly reduced the weight gains caused by a normal diet (Figs 1 and 2). Furthermore, TYJWT suppressed slightly fat accumulation in the epididymal fat pad (data not shown) without suppressing feed intake, which led to a decrease in the body weight gain. These results indirectly suggest that TYJWT decreases weight gain not only by reducing fat mass but also by reducing lean body mass. Therefore, further study is required to clarify the possible metabolic effect of TYJWT on lean body mass.

Generally, leptin is secreted by fat tissues and controlled by neuropeptide Y from the thalamus, which reduces food intake and suppresses weight gain (15). But, when its secretion is excessive, or when leptin exposure is prolonged, it accelerates lipolysis and increases energy use (16). The lower leptin concentration observed in the serum of TYJWT-treated mice could not be related to the improvement of metabolic changes, such as the lipid-lowering effect of TYJWT. Considering the current state of research into the role of leptin in obesity and obesity-related genes, more research is needed.

In contrast to the appetite-suppressing effects of leptin, ghrelin, which is secreted by the stomach, increases appetite. Ghrelin has been shown to be controlled by the body's energy levels, as its levels increase during hunger and decrease when food is eaten (9). Leptin, insulin and somatostatin have been reported to be affected by the secretion of ghrelin in the stomach (9,10,17). In our tests, the 500 mg kg–1 TYJWT group showed reduced leptin expression compared to the control group. But, the levels of ghrelin increased proportionately to the dosage of TYJWT given. According to research on the effects of leptin and ghrelin on appetite and weight (9,17), TYJWT extract increased appetite and weight, yet in our tests, TYJWT extract resulted in reduced weight. According to Toshinai (18), when leptin was given to mice for 5 days, the ghrelin mRNA levels increased. However, Asakawa et al. (9) reported that leptin decreased the expression of ghrelin. Initial reports showed that leptin is secreted by fat tissues (19), but it is now known that it is also secreted from various tissues, including the stomach (20). The possibility that the leptin-reducing effect of TYJWT is due to its influence on leptin expression and secretion by other tissues besides fat tissue cannot be excluded, and further research is necessary. Also, we conclude that leptin influences the expression of ghrelin in the stomach.

Recently, fat tissue has been found not only to store fat but also to secrete adipocytokines, such as adiponectin, leptin and TNF-{alpha}. Recent research shows that serum adiponectin levels are lower in obesity that is accompanied by type 2 diabetes (21). Resistin increases insulin resistance and fat synthesis. Thus, in resistin knock-out mice, glucose intolerance was improved and fat synthesis was suppressed in the fat tissues (22). As shown in Fig. 4, TYJWT extract did not influence the serum adiponectin levels, but it did reduce the resistin levels inversely according to the dosage. We can analogize that TYJWT extract lowers weight by suppressing fat synthesis due to decreased food intake, but the lipolysis effects of TYJWT cannot be excluded.

In our tests, TYJWT reduced the weights of mice that were fed a normal diet. Along with previous results showing that TYJWT extract suppressed obesity in high-fat-diet-fed mice (2–4), these results will be a basis for the development of TYJWT as an anti-obesity medication. For the future, more detailed research into the mechanisms of TYJWT's anti-obesity effects must be done.


   Funding
Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Funding
References
 
Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST) (Grant No. M10643020001-08N4302-00100); Korea Institute of Oriental Medicine grant funded by the Korean government (Grant No. K08020).


  Footnotes
 
For reprints and all correspondence: Prof. Kang-Beom Kwon, Department of Physiology, College of Oriental Medicine, Wonkwang University, 344-2 Shinyoung-dong, Iksan, Chonbuk 570-749, Republic of Korea. Tel: +82-63-850-6917; Fax: +82-63-842-3138; E-mail: desson{at}wonkwang.ac.kr


   References
Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Funding
 References
 

  1. Lee JM. Donguisusebowon ( 1993;) Seoul: Daesung Books.
  2. Park SS, Cho SW. Effects of Taeyeumjoweetang on loss in weight, plasma lipids and UCPI revelation of fated white rats. J Korean Oriental Med ( 2004;) 25:: 87–97.
  3. Lim YT, Lee JM. Effects of Taeyumjoweetang herbal acupuncture on plasma and liver lipid composition and antioxidative capacity in rat fed high fat diet. J Meridian Acupoint Med ( 2005;) 22:: 151–61.
  4. Shin DJ, Kim DR, Kim SH. The effect of Taeumjowetang and Herba Ephedrae on the obese mRNA and TNF-{alpha} mRNA in obesity-induced rats. J Sasang Constitutional Med ( 2001;) 13:: 79–87.
  5. Devlin MJ, Yanovski SZ, Wilson GT. Obesity: what mental health professionals need to know. Am J Psychiatry ( 2000;) 157:: 854–66.[Abstract/Free Full Text]
  6. Fujioka K. Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options. Obes Res ( 2002;) 10:: 116S–23S.[Web of Science][Medline]
  7. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature ( 1997;) 389:: 374–7.[CrossRef][Medline]
  8. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature ( 1999;) 402:: 656–60.[CrossRef][Medline]
  9. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology ( 2004;) 120:: 337–45.[CrossRef]
  10. Lucidi P, Murdolo G, Di Loreto C, De Cicco A, Parlanti N, Fanelli C, et al. Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia. Diabetes ( 2002;) 51:: 2911–14.[Abstract/Free Full Text]
  11. The Korean Academy of Oriental Rehabilitation Medicine. Oriental Rehabilitation Medicine ( 2003;) Seoul: Kuja Books.
  12. Park HS. Obesity and weight control. J Fam Med ( 1992;) 13:: 289–99.
  13. Park YW. Evidence-based prescriptions of functional foods for weight control. J Fam Med ( 2003;) 24:: 409–15.
  14. Park CY. The update of anti-obesity drug. J Kyung Hee University Medical Center ( 2002;) 18:: 77–85.
  15. Bjorbaek C, Kahn BB. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res ( 2004;) 59:: 305–31.[Abstract/Free Full Text]
  16. Dobbins RL, Szczepaniak LS, Zhang W, McGarry JD. Chemical sympathectomy alters regulation of body weight during prolonged ICV leptin infusion. Am J Physiol Endocrinol Metab ( 2003;) 284:: E778–87.[Abstract/Free Full Text]
  17. Ariyasu H, Takaya K, Tagami T. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab ( 2001;) 86:: 4753–8.[Abstract/Free Full Text]
  18. Toshinai K, Mondal MS, Nakazato M. Upregulation of ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem Biophys Res Commun ( 2001;) 281:: 1220–5.[CrossRef][Web of Science][Medline]
  19. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature ( 1994;) 372:: 425–32.[CrossRef][Medline]
  20. Wang MY, Zhou YT, Newgard CB, Unger RH. A novel leptin receptor isoform in rat. FEBS Lett ( 1996;) 392:: 87–90.[CrossRef][Web of Science][Medline]
  21. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol ( 2000;) 20:: 1595–9.[Abstract/Free Full Text]
  22. Kim KH, Zhao L, Moon Y, Kang C, Sul HS. Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity. Proc Natl Acad Sci USA ( 2004;) 101:: 6780–5.[Abstract/Free Full Text]
Received March 16, 2009; accepted July 9, 2009


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Lee, S.-W.
Right arrow Articles by Kwon, K.-B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, S.-W.
Right arrow Articles by Kwon, K.-B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?